Skip to main content
Top

03-04-2024 | Hepatitis A | Original Article

Prognostic markers in hepatitis A–related pediatric acute liver failure and validation of the Peds-hepatitis A virus prognostic model

Authors: Sanjeev Kumar Verma, Piyush Upadhyay, Stuti Shukla, Amita Jain, Suruchi Shukla, Ajay Kumar Patwa

Published in: Indian Journal of Gastroenterology

Login to get access

Abstract

Objectives

Hepatitis A virus (HAV) is the commonest cause for pediatric acute liver failure (PALF) in India. The objective of the study was to identify the predictors of mortality and to evaluate the utility of Peds-HAV model in a cohort of non-LT HAV-PALF.

Methods

The study included HAV-related PALF from two non-transplant centers. The predictors of outcome were identified by univariate analysis followed by Cox regression analysis. The prognostic accuracy of Peds-HAV model, King’s College Hospital (KCH) criteria and pediatric end-stage liver disease score (PELD) were evaluated.

Results

As many as 140 children with PALF were included, of whom 96 (68.6%) children had HAV-PALF. On Cox regression analysis, international normalized ratio (INR) (p < 0.001), jaundice to encephalopathy (JE) interval (p < 0.001) and hepatic encephalopathy (HE) grade 3/4 (p = 0.01) were independent predictors of mortality. The mortality rates were 0% (0/42), 14.3% (3/21), 60% (9/15) and 94.4% (17/18) when none, 1, 2 or 3 criteria of the Peds-HAV were met, respectively. Peds-HAV model at a listing cut-off of  ≥ 2 criteria predicted death with 89.7% sensitivity and 89.6% specificity. In contrast, KCH criteria had a lower sensitivity of 62.1%. PELD score had a sensitivity of 89.7% and specificity of 85.1% at a cut-off of 30. The overall prognostic accuracy of Peds-HAV model (89.6%) was higher than those of KCH (83.3%) and PELD (86.5%).

Conclusion

INR, HE grade and JE interval were independent predictors of mortality. The study provides an external validation of Peds-HAV model as a prognostic score in HAV-PALF.

Clinical trial registry number

Not applicable as this is a retrospective study.

Graphical abstract

Appendix
Available only for authorised users
Literature
2.
go back to reference Squires RH Jr, Shneider BL, Bucuvalas J, et al. Acute liver failure in children: the first 348 patients in the pediatric acute liver failure study group. J Pediatr. 2006;148:652–8.CrossRefPubMedPubMedCentral Squires RH Jr, Shneider BL, Bucuvalas J, et al. Acute liver failure in children: the first 348 patients in the pediatric acute liver failure study group. J Pediatr. 2006;148:652–8.CrossRefPubMedPubMedCentral
4.
go back to reference Zellos A, Debray D, Indolfi G, et al. Proceedings of the European Society for Pediatric Gastroenterology, Hepatology and Nutrition Monothematic Conference, 2020: “Acute Liver Failure in Children”: Treatment and Directions for Future Research. J Pediatr Gastroenterol Nutr. 2022;74:338–47.CrossRefPubMed Zellos A, Debray D, Indolfi G, et al. Proceedings of the European Society for Pediatric Gastroenterology, Hepatology and Nutrition Monothematic Conference, 2020: “Acute Liver Failure in Children”: Treatment and Directions for Future Research. J Pediatr Gastroenterol Nutr. 2022;74:338–47.CrossRefPubMed
5.
go back to reference O'Grady JG, Alexander GJ, Hayllar KM, Williams R. Early indicators of prognosis in fulminant hepatic failure. Gastroenterology. 1989;97:439–45.CrossRefPubMed O'Grady JG, Alexander GJ, Hayllar KM, Williams R. Early indicators of prognosis in fulminant hepatic failure. Gastroenterology. 1989;97:439–45.CrossRefPubMed
6.
go back to reference Rajanayagam J, Coman D, Cartwright D, Lewindon PJ. Pediatric acute liver failure: etiology, outcomes, and the role of serial pediatric end-stage liver disease scores. Pediatr Transplantation. 2013;17:362–8.CrossRef Rajanayagam J, Coman D, Cartwright D, Lewindon PJ. Pediatric acute liver failure: etiology, outcomes, and the role of serial pediatric end-stage liver disease scores. Pediatr Transplantation. 2013;17:362–8.CrossRef
7.
go back to reference Sanchez MC, D’Agostino DE. Pediatric end-stage liver disease score in acute liver failure to assess poor prognosis. J Pediatr Gastroenterol Nutr. 2012;54:193–6.CrossRefPubMed Sanchez MC, D’Agostino DE. Pediatric end-stage liver disease score in acute liver failure to assess poor prognosis. J Pediatr Gastroenterol Nutr. 2012;54:193–6.CrossRefPubMed
8.
go back to reference Liu E, MacKenzie T, Dobyns EL, et al. Characterization of acute liver failure and development of a continuous risk of death staging system in children. J Hepatol. 2006;44:134–41.CrossRefPubMed Liu E, MacKenzie T, Dobyns EL, et al. Characterization of acute liver failure and development of a continuous risk of death staging system in children. J Hepatol. 2006;44:134–41.CrossRefPubMed
9.
go back to reference Lu BR, Zhang S, Narkewicz MR, et al. Evaluation of the liver injury unit scoring system to predict survival in a multinational study of pediatric acute liver failure. J Pediatr. 2013;162:1010-6.e1-4.CrossRefPubMed Lu BR, Zhang S, Narkewicz MR, et al. Evaluation of the liver injury unit scoring system to predict survival in a multinational study of pediatric acute liver failure. J Pediatr. 2013;162:1010-6.e1-4.CrossRefPubMed
11.
go back to reference Mcphail MJ, Farne H, Senvar N, et al. Ability of King’s College criteria and model for end-stage liver disease scores to predict mortality of patients with acute liver failure: a meta-analysis. Clin Gastroenterol Hepatol. 2016;14:516-25.e5.CrossRefPubMed Mcphail MJ, Farne H, Senvar N, et al. Ability of King’s College criteria and model for end-stage liver disease scores to predict mortality of patients with acute liver failure: a meta-analysis. Clin Gastroenterol Hepatol. 2016;14:516-25.e5.CrossRefPubMed
12.
go back to reference Sundaram V, Shneider BL, Dhawan A, et al. King’s College Hospital Criteria for non-acetaminophen induced acute liver failure in an international cohort of children. J Pediatr. 2013;162:319-23.e1.CrossRefPubMed Sundaram V, Shneider BL, Dhawan A, et al. King’s College Hospital Criteria for non-acetaminophen induced acute liver failure in an international cohort of children. J Pediatr. 2013;162:319-23.e1.CrossRefPubMed
13.
go back to reference Jain V, Dhawan A. Prognostic modeling in pediatric acute liver failure. Liver Transpl. 2016;22:1418–30.CrossRefPubMed Jain V, Dhawan A. Prognostic modeling in pediatric acute liver failure. Liver Transpl. 2016;22:1418–30.CrossRefPubMed
14.
go back to reference Lal BB, Sood V, Snehavardhan P, et al. A novel, bedside, etiology specific prognostic model (Peds-HAV) in hepatitis A induced pediatric acute liver failure. Hepatol Int. 2020;14:483–90.CrossRefPubMed Lal BB, Sood V, Snehavardhan P, et al. A novel, bedside, etiology specific prognostic model (Peds-HAV) in hepatitis A induced pediatric acute liver failure. Hepatol Int. 2020;14:483–90.CrossRefPubMed
15.
go back to reference Alam S, Khanna R, Sood V, Lal BB, Rawat D. Profile and outcome of first 109 cases of paediatric acute liver failure at a specialized paediatric liver unit in India. Liver Int. 2017;37:1508–14.CrossRefPubMed Alam S, Khanna R, Sood V, Lal BB, Rawat D. Profile and outcome of first 109 cases of paediatric acute liver failure at a specialized paediatric liver unit in India. Liver Int. 2017;37:1508–14.CrossRefPubMed
16.
go back to reference Kaur S, Kumar P, Kumar V, et al. Etiology and prognostic factors of acute liver failure in children. Indian Pediatr. 2013;50:677–9.CrossRefPubMed Kaur S, Kumar P, Kumar V, et al. Etiology and prognostic factors of acute liver failure in children. Indian Pediatr. 2013;50:677–9.CrossRefPubMed
17.
18.
go back to reference Kayaalp C, Ersan V, Yılmaz S. Acute liver failure in Turkey: a systematic review. Turk J Gastroenterol. 2014;25:35–40.CrossRefPubMed Kayaalp C, Ersan V, Yılmaz S. Acute liver failure in Turkey: a systematic review. Turk J Gastroenterol. 2014;25:35–40.CrossRefPubMed
19.
go back to reference Aggarwal R, Goel A. Hepatitis A: epidemiology in resource-poor countries. Curr Opin Infect Dis. 2015;28:488–96.CrossRefPubMed Aggarwal R, Goel A. Hepatitis A: epidemiology in resource-poor countries. Curr Opin Infect Dis. 2015;28:488–96.CrossRefPubMed
20.
go back to reference Nagral A, Sarma MS, Matthai J, et al. Wilson's disease: Clinical practice guidelines of the Indian National Association for the Study of Liver (INASL), The Indian Society of Pediatric Gastroenterology, Hepatology and Nutrition (ISPGHAN) and the Movement Disorders Society of India (MDSI). J Clin Exp Hepatol. 2019;9:74–98.CrossRefPubMed Nagral A, Sarma MS, Matthai J, et al. Wilson's disease: Clinical practice guidelines of the Indian National Association for the Study of Liver (INASL), The Indian Society of Pediatric Gastroenterology, Hepatology and Nutrition (ISPGHAN) and the Movement Disorders Society of India (MDSI). J Clin Exp Hepatol. 2019;9:74–98.CrossRefPubMed
21.
go back to reference Reddy MS, Rajakumar A, Mathew JS, et al. Liver Transplantation Society of India guidelines for the management of acute liver injury secondary to yellow phosphorus-containing rodenticide poisoning using the modified Delphi technique of consensus development. J Clin Exp Hepatol. 2021;11:475–83.CrossRefPubMed Reddy MS, Rajakumar A, Mathew JS, et al. Liver Transplantation Society of India guidelines for the management of acute liver injury secondary to yellow phosphorus-containing rodenticide poisoning using the modified Delphi technique of consensus development. J Clin Exp Hepatol. 2021;11:475–83.CrossRefPubMed
22.
go back to reference Maiwall R, Bajpai M, Singh A, et al. Standard-volume plasma exchange improves outcomes in patients with acute liver failure: a randomized controlled trial. Clin Gastroenterol Hepatol. 2022;20:e831–54.CrossRefPubMed Maiwall R, Bajpai M, Singh A, et al. Standard-volume plasma exchange improves outcomes in patients with acute liver failure: a randomized controlled trial. Clin Gastroenterol Hepatol. 2022;20:e831–54.CrossRefPubMed
23.
go back to reference Sood V, Lal BB, Gupta E, Khanna R, Siloliya MK, Alam S. Hepatitis A virus-related pediatric liver disease burden and its significance in the Indian subcontinent. Indian Pediatr. 2019;56:741–4.CrossRefPubMed Sood V, Lal BB, Gupta E, Khanna R, Siloliya MK, Alam S. Hepatitis A virus-related pediatric liver disease burden and its significance in the Indian subcontinent. Indian Pediatr. 2019;56:741–4.CrossRefPubMed
24.
go back to reference McDiarmid SV, Anand R, Lindblad AS, Principal Investigators and Institutions of the Studies of Pediatric Liver Transplantation (SPLIT) Research Group. Development of a pediatric end-stage liver disease score to predict poor outcome in children awaiting liver transplantation. Transplantation. 2002;74:173–81.CrossRefPubMed McDiarmid SV, Anand R, Lindblad AS, Principal Investigators and Institutions of the Studies of Pediatric Liver Transplantation (SPLIT) Research Group. Development of a pediatric end-stage liver disease score to predict poor outcome in children awaiting liver transplantation. Transplantation. 2002;74:173–81.CrossRefPubMed
25.
go back to reference Chien MM, Chang MH, Chang KC, et al. Prognostic parameters of pediatric acute liver failure and the role of plasma exchange. Pediatr Neonatol. 2019;60:389–95.CrossRefPubMed Chien MM, Chang MH, Chang KC, et al. Prognostic parameters of pediatric acute liver failure and the role of plasma exchange. Pediatr Neonatol. 2019;60:389–95.CrossRefPubMed
26.
go back to reference Walabh P, Meyer A, de Maayer T, et al. Prognostic factors and scoring systems associated with outcome in pediatric acute liver failure. BMC Pediatr. 2022;22:516.CrossRefPubMedPubMedCentral Walabh P, Meyer A, de Maayer T, et al. Prognostic factors and scoring systems associated with outcome in pediatric acute liver failure. BMC Pediatr. 2022;22:516.CrossRefPubMedPubMedCentral
27.
go back to reference Pop TL, Aldea CO, Delean D, et al. The role of predictive models in the assessment of the poor outcomes in pediatric acute liver failure. J Clin Med. 2022;11:432.CrossRefPubMedPubMedCentral Pop TL, Aldea CO, Delean D, et al. The role of predictive models in the assessment of the poor outcomes in pediatric acute liver failure. J Clin Med. 2022;11:432.CrossRefPubMedPubMedCentral
28.
go back to reference Amatya P, Kapalavai SK, Deep A, et al. Pediatric acute liver failure: an experience of a pediatric intensive care unit from resource limited settings. Front Pediatr. 2022;10:956699.CrossRefPubMedPubMedCentral Amatya P, Kapalavai SK, Deep A, et al. Pediatric acute liver failure: an experience of a pediatric intensive care unit from resource limited settings. Front Pediatr. 2022;10:956699.CrossRefPubMedPubMedCentral
29.
go back to reference Fang WY, Abuduxikuer K, Shi P, et al. Pediatric Wilson disease presenting as acute liver failure: prognostic indices. World J Clin Cases. 2021;9:3273–86.CrossRefPubMedPubMedCentral Fang WY, Abuduxikuer K, Shi P, et al. Pediatric Wilson disease presenting as acute liver failure: prognostic indices. World J Clin Cases. 2021;9:3273–86.CrossRefPubMedPubMedCentral
Metadata
Title
Prognostic markers in hepatitis A–related pediatric acute liver failure and validation of the Peds-hepatitis A virus prognostic model
Authors
Sanjeev Kumar Verma
Piyush Upadhyay
Stuti Shukla
Amita Jain
Suruchi Shukla
Ajay Kumar Patwa
Publication date
03-04-2024
Publisher
Springer India
Published in
Indian Journal of Gastroenterology
Print ISSN: 0254-8860
Electronic ISSN: 0975-0711
DOI
https://doi.org/10.1007/s12664-024-01551-z
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.